HKPD
Hong Kong Pharma Digital Technology Holdings Ltd (HKPD)
Healthcare • NASDAQ • $0.11-2.97%
- Symbol
- HKPD
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Distribution
- Price
- $0.11
- Daily Change
- -2.97%
- Market Cap
- $5.43M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $1.72
- 52W Low
- $0.10
- Analyst Target
- N/A
- Dividend Yield
- 0.00%
- Beta
- N/A
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Ho…
Company websiteResearch HKPD on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.